MONTELUKAST

Trials studying MONTELUKAST

• phase1A Clinical Trial to Evaluate MK-4208/Embibatinib in Healthy Adult Participants (MK-4208-001/Embibatinib-1014)completedn=196
• phase3SC Versus IV Isatuximab in Combination With Pomalidomide and Dexamethasone in RRMMactive not recruitingn=531
• phase2Premedication to Reduce Amivantamab Associated Infusion Related Reactionsactive not recruitingn=68
• phase2A Study of Daratumumab, Carfilzomib, Lenalidomide, and Dexamethasone in Patients With Newly-Diagnosed Multiple Myelomaactive not recruitingn=310
• phase2Iberdomide, Daratumumab, Carfilzomib, and Dexamethasone (Iber-KDd) in Patients With Relapsed/Refractory Multiple Myelomarecruitingn=30
• phase2A Study to Investigate Subcutaneous Isatuximab in Combination With Weekly Carfilzomib and Dexamethasone in Adult Participants With Relapsed and/or Refractory Multiple Myelomarecruitingn=64
• phase2BElumosudil for Bronchiolitis Obliterans Prevention/Therapy (BEBOP)recruitingn=45
• phase4Evaluating Premedication Regimens (Methylprednisolone vs Dexamethasone-based) for the Prevention of Systemic and Injection Site Reactions to Motixafortide in Patients With Multiple Myeloma Undergoing Stem Cell Mobilization, PARADE Trialrecruitingn=94